Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle D Wood

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Clinical Kidney Journal|May 20, 2022
Primary hyperoxaluria type 1: time for prime time?Justine Bacchetta, Kyle D Wood
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 22, 2022
Progress with RNA Interference for the Treatment of Primary HyperoxaluriaKathryn Sawyer, Stephen Leahy, Kyle D Wood
Indian Journal of Urology : IJU : Journal of the Urological Society of India|February 6, 2014
Medical expulsive therapyKyle D Wood, Ilya Gorbachinsky, Jorge Gutierrez
International Journal of Surgery (London, England)|November 17, 2016
RNA interference in the treatment of renal stone disease: Current status and future potentialsKyle D Wood, Ross P Holmes, John Knight
Journal of Endourology|August 19, 2021
Is It Time to Retire the Low-Oxalate Diet? No!Joseph J Crivelli, Kyle D Wood, Dean G Assimos
The New England Journal of Medicine|May 24, 2023
Hydrochlorothiazide and Prevention of Kidney-Stone RecurrenceVikram S Lyall, Kyle D Wood, Vernon M Pais
Urology|June 17, 2011
Oxalate and sucralose absorption in idiopathic calcium oxalate stone formersJohn Knight, Juquan Jiang, Kyle D Wood, et al.
Advances in Urology|May 9, 2012
Glyoxal formation and its role in endogenous oxalate synthesisJessica N Lange, Kyle D Wood, John Knight, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 6, 2019
Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activityKyle D Wood, Ross P Holmes, David Erbe, et al.
Urology|November 8, 2015
Oxalate Formation From Glyoxal in ErythrocytesJohn Knight, Kyle D Wood, Jessica N Lange, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Clinical Kidney Journal|May 20, 2022
Primary hyperoxaluria type 1: time for prime time?Justine Bacchetta, Kyle D Wood
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 22, 2022
Progress with RNA Interference for the Treatment of Primary HyperoxaluriaKathryn Sawyer, Stephen Leahy, Kyle D Wood
Indian Journal of Urology : IJU : Journal of the Urological Society of India|February 6, 2014
Medical expulsive therapyKyle D Wood, Ilya Gorbachinsky, Jorge Gutierrez
International Journal of Surgery (London, England)|November 17, 2016
RNA interference in the treatment of renal stone disease: Current status and future potentialsKyle D Wood, Ross P Holmes, John Knight
Journal of Endourology|August 19, 2021
Is It Time to Retire the Low-Oxalate Diet? No!Joseph J Crivelli, Kyle D Wood, Dean G Assimos
The New England Journal of Medicine|May 24, 2023
Hydrochlorothiazide and Prevention of Kidney-Stone RecurrenceVikram S Lyall, Kyle D Wood, Vernon M Pais
Urology|June 17, 2011
Oxalate and sucralose absorption in idiopathic calcium oxalate stone formersJohn Knight, Juquan Jiang, Kyle D Wood, et al.
Advances in Urology|May 9, 2012
Glyoxal formation and its role in endogenous oxalate synthesisJessica N Lange, Kyle D Wood, John Knight, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 6, 2019
Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activityKyle D Wood, Ross P Holmes, David Erbe, et al.
Urology|November 8, 2015
Oxalate Formation From Glyoxal in ErythrocytesJohn Knight, Kyle D Wood, Jessica N Lange, et al.
Pageof 4